PDF(Pubmed)
Abstract：
BACKGROUND: Readmission, defined as any admission after discharge from the same hospital, has negative implications for health outcomes. This study aims to identify the sociodemographic and clinical factors associated with hospital readmission among psychiatric patients.
METHODS: This case-control study analyzed 202 clinical records of patients admitted to a psychiatric hospital between 2019-2021. The sample was selected using simple random sampling. Qualitative variables were presented using frequencies, percentages, and chi-square tests for association. Quantitative variables were described using central tendency measures and dispersion of data, investigated with the Kolmogorov-Smirnov test, Student\'s t-test or Wilcoxon test as appropriate. Regression analysis was conducted to determine factors linked to readmission. p < 0.05 was considered.
RESULTS: Women accounted for a higher readmission rate (59%). Patients diagnosed with schizophrenia had a higher readmission rate (63%), experienced longer transfer times to the hospital during readmissions, and had shorter hospital stays. Polypharmacy and pharmacological interactions were associated with readmission. Olanzapine treatment was identified as a risk factor for readmission (ExpB = 3.203, 95% CI 1.405-7.306, p = 0.006).
CONCLUSIONS: The findings suggest avoiding polypharmacy and medications with high side effect profiles to reduce readmissions. This study offers valuable insights for clinical decision-making from admission to discharge planning, aiming to enhance the quality of care.
METHODS: This case-control study analyzed 202 clinical records of patients admitted to a psychiatric hospital between 2019-2021. The sample was selected using simple random sampling. Qualitative variables were presented using frequencies, percentages, and chi-square tests for association. Quantitative variables were described using central tendency measures and dispersion of data, investigated with the Kolmogorov-Smirnov test, Student\'s t-test or Wilcoxon test as appropriate. Regression analysis was conducted to determine factors linked to readmission. p < 0.05 was considered.
RESULTS: Women accounted for a higher readmission rate (59%). Patients diagnosed with schizophrenia had a higher readmission rate (63%), experienced longer transfer times to the hospital during readmissions, and had shorter hospital stays. Polypharmacy and pharmacological interactions were associated with readmission. Olanzapine treatment was identified as a risk factor for readmission (ExpB = 3.203, 95% CI 1.405-7.306, p = 0.006).
CONCLUSIONS: The findings suggest avoiding polypharmacy and medications with high side effect profiles to reduce readmissions. This study offers valuable insights for clinical decision-making from admission to discharge planning, aiming to enhance the quality of care.
摘要：
背景：重新入学，定义为从同一医院出院后的任何入院，对健康结果有负面影响。这项研究旨在确定与精神病患者再次入院相关的社会人口统计学和临床因素。
方法：这项病例对照研究分析了2019-2021年间精神病医院收治的202例患者的临床记录。采用简单随机抽样法选择样本。定性变量使用频率表示，百分比,和卡方检验的关联性。使用集中趋势度量和数据分散来描述定量变量，用Kolmogorov-Smirnov检验进行调查,学生t检验或Wilcoxon检验视情况而定。进行回归分析以确定与再入院相关的因素。考虑p<0.05。
结果：女性的再入院率较高（59%）。诊断为精神分裂症的患者有更高的再入院率（63%），在再入院期间经历了更长的转移时间，住院时间较短。多重药物和药理学相互作用与再次入院相关。奥氮平治疗被确定为再入院的危险因素(ExpB=3.203,95%CI1.405-7.306,p=0.006)。
结论：研究结果表明，避免多重用药和高副作用药物，以减少再入院。这项研究为从入院到出院计划的临床决策提供了有价值的见解，旨在提高护理质量。
方法：这项病例对照研究分析了2019-2021年间精神病医院收治的202例患者的临床记录。采用简单随机抽样法选择样本。定性变量使用频率表示，百分比,和卡方检验的关联性。使用集中趋势度量和数据分散来描述定量变量，用Kolmogorov-Smirnov检验进行调查,学生t检验或Wilcoxon检验视情况而定。进行回归分析以确定与再入院相关的因素。考虑p<0.05。
结果：女性的再入院率较高（59%）。诊断为精神分裂症的患者有更高的再入院率（63%），在再入院期间经历了更长的转移时间，住院时间较短。多重药物和药理学相互作用与再次入院相关。奥氮平治疗被确定为再入院的危险因素(ExpB=3.203,95%CI1.405-7.306,p=0.006)。
结论：研究结果表明，避免多重用药和高副作用药物，以减少再入院。这项研究为从入院到出院计划的临床决策提供了有价值的见解，旨在提高护理质量。
